E Rapp
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Oncology 4
- Lung Cancer Research Studies 2
- Co-authors
- Joseph L. Pater (4 shared papers)Nevin Murray (3 shared papers)Yvon Cormier (2 shared papers)Ronald Feld (1 shared paper)William K. Evans (1 shared paper)Andrew R. Willan (1 shared paper)D. Ian Hodson (1 shared paper)DavidA. Clark (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Canadian Medical Association Journal (2 papers)Radiotherapy and Oncology (1 paper)The Lancet (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
E Rapp
13 papers receiving 1.3k citations
E Rapp's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 663
- Pulmonary and Respiratory Medicine 769
- Otorhinolaryngology 33
- Cancer Research 74
- Hepatology 34
Countries citing papers authored by E Rapp
This map shows the geographic impact of E Rapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Rapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Rapp more than expected).
Fields of papers citing papers by E Rapp
This network shows the impact of papers produced by E Rapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Rapp. The network helps show where E Rapp may publish in the future.
Co-authors
The 25 scholars most cited alongside E Rapp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Hit paper breakdown → | 1988 | 570 |
| 2 | 1993 | 407 | |
| 3 | 1990 | 172 | |
| 4 | Progress in Cancer Research and Therapy. | 1978 | 167 |
| 5 | 1976 | 35 | |
| 6 | 1998 | 29 | |
| 7 | 1994 | 11 | |
| 8 | 2001 | 10 | |
| 9 | Ackerman and del Regato's Cancer | 1977 | 9 |
| 10 | 1979 | 8 | |
| 11 | Specific active immunochemotherapy in lung cancer: a survival study. | 1977 | 8 |
| 12 | Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. | 1975 | 1 |
| 13 | 1978 | 1 |
About E Rapp
E Rapp is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Immunology, having authored 13 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers), Head and Neck Cancer Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Glycosylation and Glycoproteins Research (2 papers), Acute Lymphoblastic Leukemia research (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (663 citations), Pulmonary and Respiratory Medicine (769 citations), Otorhinolaryngology (33 citations), Cancer Research (74 citations) and Hepatology (34 citations). E Rapp has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Joseph L. Pater, Nevin Murray, Yvon Cormier, Ronald Feld, William K. Evans, Andrew R. Willan, D. Ian Hodson, DavidA. Clark, Andrew Arnold and J. P. Bernard. Their work appears in journals such as Journal of Clinical Oncology, Canadian Medical Association Journal, Radiotherapy and Oncology, The Lancet and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.